pharma · Heart Valve Diseases · Angina, Stable
Beijing Anzhen Hospital
Beijing Anzhen Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Heart Valve Diseases, Angina, Stable. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 pat
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 2
- Drugs
- 1
- Patents
- 0
CYP2C19 genotype testing
Unknown · gene therapy · Angina, Stable
CYP2C19 genotype testing for Angina, Stable is a Unknown program (gene_therapy) at Beijing Anzhen Hospital with 1 ClinicalTrials.gov record(s).
Internal code GUARANTEE
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Beijing Anzhen Hospital
- Phase
- Unknown
- Modality
- gene_therapy
- Indication
- Angina, Stable
- Status
- active
- Trials
- 1